Home » Topics » Regulatory » Patents

Patents
RSS

Human Genome Sciences discloses novel approach to malignancy

Oct. 4, 1996

delta-Opioid antagonists for non-CNS applications

Oct. 4, 1996

Fournier investigates deoxyspergualin analogues

Oct. 4, 1996

Enzyme inhibitor for autoimmune diseases isolated by Japanese researchers

Oct. 4, 1996

Mercian investigators report new antiarthritic compounds

Oct. 4, 1996

Merck Frosst discloses a new series of COX-2 inhibitors

Oct. 4, 1996

Matrix metalloproteinase inhibitors disclosed by Roche Bioscience

Oct. 4, 1996

More COX-2 inhibitors from Searle

Oct. 4, 1996

Dana Farber discloses unique antiherpetic therapy

Oct. 4, 1996

Antiherpesvirus agents from Eisai

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...